The immunosuppressive effects of long-term combination chemotherapy in children with acute leukemia in remission.
D000917:Antibody Formation; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D006385:Hemagglutination Inhibition Tests; D006389:Hemagglutinins, Viral; D006801:Humans; D007108:Immune Tolerance; D005779:Immunodiffusion; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007136:Immunoglobulins; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007252:Influenza Vaccines; D037102:Lectins / Q000494:pharmacology; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000276:immunology*; D008134:Long-Term Care; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology; D008623:Mercaptoethanol; D009439:Neuraminidase; D009975:Orthomyxoviridae / Q000276:immunology; D012075:Remission, Spontaneous; D013997:Time Factors; D014611:Vaccination
D000970:Antineoplastic Agents; D006389:Hemagglutinins, Viral; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D007166:Immunosuppressive Agents; D007252:Influenza Vaccines; D037102:Lectins; D008623:Mercaptoethanol; D009439:Neuraminidase